Exosomes derived from human dental stem cell enhance the viability of odontoblasts

Document Type : Original Research Article


Department of dentistry, Islamic Azad University, Tehran, Iran


Objective(s): The purpose of this study was to assess the effects of exosomes derived from dental pulp mesenchymal stem cells (DPSCs) on the viability of odontoblast cells.
Methods: Exosomes were extracted from human DPSC cells via ultracentrifugation. Scanning electron microscopy and western blot analysis for CD9 and CD81 demonstrated characteristics of exosomes. Developing odontoblasts were exposed to increasing concentrations of exosomes (10-400 ng/ml) over time periods of 24, 48, 72, and 96 hours. Cell viability was evaluated using MTT assays. In addition, real-time PCR was used to assess expression levels of Wnt, beta-catenin, PI3K, Akt, Bcl-2, and Bax in cells after 24-96 hours of exposure to 100 and 400 ng/ml exosomes.
Results: Odontoblast viability was found to be enhanced by DPSC-derived exosomes, with greater impacts at higher concentrations and time periods of 72-96 hours. Expression of PI3K, AKT, Wnt, beta-catenin, and Bcl-2 were notably upregulated in odontoblasts following 96 hours of DPSC-exosome treatment. Conversely, Bax expression was significantly downregulated. These findings suggest DPSC-exosomes promote odontoblast survival through modulated expression of genes involved in key survival pathways over extended exposure periods.
Conclusions: Our findings demonstrated that exosomes derived from DPSC cells possess innate nanoparticle properties, leading to enhanced survival of odontoblast cells. This effect is achieved through the activation of the Wnt/beta-catenin and P3K/AKT signaling pathways, ultimately resulting in an increased Bcl-2/Bax ratio.


Main Subjects

1. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8(8):886.
2. Maqsood M, Kang M, Wu X, Chen J, Teng L, Qiu L. Adult mesenchymal stem cells and their exosomes: Sources, characteristics, and application in regenerative medicine. Life Sciences. 2020;256:118002.
3. Yamada Y, Nakamura-Yamada S, Kusano K, Baba S. Clinical potential and current progress of dental pulp stem cells for various systemic diseases in regenerative medicine: a concise review. International journal of molecular sciences. 2019;20(5):1132.
4. Hu X, Zhong Y, Kong Y, Chen Y, Feng J, Zheng J. Lineage-specific exosomes promote the odontogenic differentiation of human dental pulp stem cells (DPSCs) through TGFβ1/smads signaling pathway via transfer of microRNAs. Stem cell research & therapy. 2019;10:1-14.
5. Sui B, Wu D, Xiang L, Fu Y, Kou X, Shi S. Dental pulp stem cells: from discovery to clinical application. Journal of endodontics. 2020;46(9):S46-S55.
6. Ji L, Bao L, Gu Z, Zhou Q, Liang Y, Zheng Y, et al. Comparison of immunomodulatory properties of exosomes derived from bone marrow mesenchymal stem cells and dental pulp stem cells. Immunologic research. 2019;67:432-42.
7. Xie L, Guan Z, Zhang M, Lyu S, Thuaksuban N, Kamolmattayakul S, et al. Exosomal circLPAR1 promoted osteogenic differentiation of homotypic dental pulp stem cells by competitively binding to hsa-miR-31. Biomed Research International. 2020;2020.
8. Li S, Luo L, He Y, Li R, Xiang Y, Xing Z, et al. Dental pulp stem cell‐derived exosomes alleviate cerebral ischaemia‐reperfusion injury through suppressing inflammatory response. Cell proliferation. 2021;54(8):e13093.
9. Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789.
10. Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, et al. Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684. https://doi.org/10.7150/thno.41580
11. Lai RC, Yeo RWY, Lim SK, editors. Mesenchymal stem cell exosomes. Semin Cell Dev Biol; 2015: Elsevier.
12. Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019;8(12):1605.
13. Tang Y, Zhou Y, Li H-J. Advances in mesenchymal stem cell exosomes: a review. Stem cell research & therapy. 2021;12(1):1-12.
14. Arana-Chavez VE, Massa LF. Odontoblasts: the cells forming and maintaining dentine. The international journal of biochemistry & cell biology. 2004;36(8):1367-73.
15. Rajan S, Ljunggren A, Manton D, Björkner AE, McCullough M. Post-mitotic odontoblasts in health, disease, and regeneration. Archives of oral biology. 2020;109:104591.
16. Yu F, Huo F, Li F, Zuo Y, Wang C, Ye L. Aberrant NF-κB activation in odontoblasts orchestrates inflammatory matrix degradation and mineral resorption. International Journal of Oral Science. 2022;14(1):6.
17. Niu L, Zhang H, Liu Y, Wang Y, Li A, Liu R, et al. Microfluidic Chip for Odontoblasts in vitro. ACS Biomaterials Science & Engineering. 2019;5(9):4844-51.
18. Rahman SU, Kim W-J, Chung SH, Woo KM. Nanofibrous topography-driven altered responsiveness to Wnt5a mediates the three-dimensional polarization of odontoblasts. Materials Today Bio. 2022;17:100479.
19. Shen Z, Kuang S, Zhang Y, Yang M, Qin W, Shi X, et al. Chitosan hydrogel incorporated with dental pulp stem cell-derived exosomes alleviates periodontitis in mice via a macrophage-dependent mechanism. Bioactive materials. 2020;5(4):1113-26.
20. Li J, Ju Y, Liu S, Fu Y, Zhao S. Exosomes derived from lipopolysaccharide-preconditioned human dental pulp stem cells regulate Schwann cell migration and differentiation. Connective tissue research. 2021;62(3):277-86.
21. Liu Y, Lin L, Zou R, Wen C, Wang Z, Lin F. MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis. Cell Cycle. 2018;17(21-22):2411-22.
22. Riazifar M, Mohammadi MR, Pone EJ, Yeri A, Lasser C, Segaliny AI, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS nano. 2019;13(6):6670-88.
23. Babaei M, Rezaie J. Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations. Journal of translational medicine. 2021;19(1):1-11.
24. Wei X, Yi X, Lv H, Sui X, Lu P, Li L, et al. MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy. Cell death & disease. 2020;11(8):657.
25. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, Aguor EN, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 2013;10(3):301-12.
26. Wang K, Jiang Z, Webster KA, Chen J, Hu H, Zhou Y, et al. Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21. Stem cells translational medicine. 2017;6(1):209-22.